Spyre Therapeutics, Inc. (SYRE) — Analyst estimates
Consensus analyst estimates for Spyre Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.72 | 7 |
| 2027 | 0 | -0.86 | 3 |
| 2028 | 200K | -3.74 | 9 |
| 2029 | 50.22M | -4.16 | 3 |
| 2030 | 138.54M | -4.1 | 3 |
Consensus analyst estimates by fiscal year.